
AptarGroup, Inc.
HealthcareNYSE:ATR · New York Stock Exchange
+$1.14 today
Vol 0.26M · Avg 0.52M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$3.9B of revenue converted into $386.7M of net income for the selected period. Gross margin is 29.0% and net margin is 10.0%, showing how much revenue survives after costs and taxes. EPS is $5.84, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8B +5.4% | $3.6B +2.7% | $3.5B +5.0% | $3.3B +2.9% | $3.2B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $2.7B +19.4% | $2.2B +0.1% | $2.2B +3.0% | $2.2B +4.2% | $2.1B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $1.1B -17.6% | $1.4B +7.3% | $1.3B +8.6% | $1.2B +0.6% | $1.2B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 29.6% -8.3pp | 37.8% +1.6pp | 36.2% +1.2pp | 35.0% -0.8pp | 35.8% | 9.8% | 28.9% | 38.3% |
| Research & Development | $105.1M | $0 | $0 | $0 -100.0% | $99.8M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $499.9M -14.1% | $582.2M +2.9% | $565.8M +4.0% | $544.3M -1.3% | $551.2M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $605.0M -29.6% | $859.0M -0.0% | $859.4M +9.5% | $784.6M -3.1% | $809.3M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $287.4M +8.9% | $263.8M +6.1% | $248.6M +6.4% | $233.7M -0.5% | $234.9M | $374.2M | $1.2B | $631.8M |
| EBITDA | $831.5M +6.9% | $777.4M +17.1% | $663.8M +8.9% | $609.4M +3.9% | $586.8M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 22.0% +0.3pp | 21.7% +2.7pp | 19.0% +0.7pp | 18.3% +0.2pp | 18.2% | 5.6% | 46.3% | 42.0% |
| Operating Income | $512.3M +3.2% | $496.5M +22.9% | $404.0M +6.5% | $379.3M +9.2% | $347.3M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 13.6% -0.3pp | 13.9% +2.3pp | 11.6% +0.2pp | 11.4% +0.7pp | 10.8% | 16.6% | 24.1% | 22.0% |
| Interest Income | $11.7M -3.5% | $12.1M +176.7% | $4.4M +62.0% | $2.7M -26.4% | $3.7M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $52.7M +20.1% | $43.9M +8.6% | $40.4M -1.0% | $40.8M +34.8% | $30.3M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$21.0M +21.6% | -$26.7M +8.4% | -$29.2M +34.5% | -$44.6M -73.5% | -$25.7M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $491.4M +4.6% | $469.8M +25.3% | $374.8M +12.0% | $334.7M +4.1% | $321.7M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 13.0% -0.1pp | 13.1% +2.4pp | 10.7% +0.7pp | 10.1% +0.1pp | 10.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $98.9M +3.4% | $95.6M +5.4% | $90.6M -4.7% | $95.1M +22.0% | $78.0M | $1.3B | -$1.6B | $745.2M |
| Net Income | $392.8M +4.9% | $374.5M +31.7% | $284.5M +18.9% | $239.3M -2.0% | $244.1M | $4.9B | $4.8B | $4.7B |
| Net Margin | 10.4% -0.1pp | 10.5% +2.3pp | 8.2% +1.0pp | 7.2% -0.4pp | 7.6% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $6 +5.7% | $6 +30.2% | $4 +18.6% | $4 -1.6% | $4 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $6 +6.3% | $6 +30.1% | $4 +18.4% | $4 -0.3% | $4 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $65.7M -0.9% | $66.3M +1.1% | $65.6M +0.3% | $65.4M -0.4% | $65.7M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $66.7M -1.4% | $67.7M +1.2% | $66.9M +0.3% | $66.7M -1.4% | $67.7M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector

Globus Medical, Inc.
NYSE:GMED
$10.86B

Molina Healthcare, Inc.
NYSE:MOH
$10.44B

Masimo Corporation
NASDAQ:MASI
$9.42B

Henry Schein, Inc.
NASDAQ:HSIC
$9.31B

Halozyme Therapeutics, Inc.
NASDAQ:HALO
$8.26B

Repligen Corporation
NASDAQ:RGEN
$7.46B

Grifols, S.A.
NASDAQ:GRFS
$6.49B

Avantor, Inc.
NYSE:AVTR
$6.47B

Teleflex Incorporated
NYSE:TFX
$5.78B

Stevanato Group S.p.A.
NYSE:STVN
$4.65B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does ATR generate?
AptarGroup, Inc. (ATR) reported $3.78B of revenue in fiscal 2025.
Is ATR profitable?
AptarGroup, Inc. (ATR) reported $392.79M of net income, with a net margin of 10.4%.
Explore More
Continue the stock analysis
Jump to another research area for this company.